
  
    
      
        Introduction_NNP
        Fluid_NNP restriction_NN and_CC diuresis_NNS are_VBP frequently_RB used_VBN in_IN
        the_DT management_NN of_IN the_DT acute_JJ respiratory_JJ distress_NN syndrome_NN
        (_( ARDS_NNP )_) ,_, and_CC a_DT strategy_NN of_IN reduction_NN in_IN extravascular_NN lung_NN
        water_NN (_( EVLW_NNP )_) has_VBZ been_VBN shown_VBN to_TO reduce_VB both_DT ventilator_NN and_CC
        intensive_JJ care_NN unit_NN (_( ICU_NNP )_) days_NNS [_NN 1_CD ]_NN ._.
        Intrathoracic_NNP blood_NN volume_NN (_( ITBV_NNP )_) comprises_VBZ the_DT left_NN and_CC
        right_JJ heart_NN blood_NN volumes_NNS and_CC the_DT pulmonary_JJ blood_NN volume_NN ,_,
        and_CC has_VBZ been_VBN shown_VBN to_TO be_VB a_DT better_JJR indicator_NN of_IN cardiac_JJ
        filling_NN than_IN the_DT pulmonary_JJ artery_NN occlusion_NN pressure_NN (_( PAOP_NNP )_)
        [_NN 2_CD ]_NN ._. Both_DT EVLW_NNP and_CC ITBV_NNP are_VBP measured_VBN using_VBG
        double-indicator_JJ dilution_NN and_CC the_DT COLD_NNP Z-_NNP 021_CD system_NN
        (_( Pulsion_NNP Medical_NNP Systems_NNPS ,_, Munich_NNP ,_, Germany_NNP )_) which_WDT requires_VBZ
        the_DT insertion_NN of_IN a_DT catheter_NN into_IN the_DT femoral_NN artery_NN through_IN
        a_DT 4_CD ._. 5_CD F_NN sheath_NN ._. The_DT technique_NN also_RB measures_VBZ cardiac_JJ output_NN
        by_IN analysis_NN of_IN the_DT femoral_NN artery_NN thermodilution_NN curve_NN ._.
        Digital_NN ischaemia_NN ,_, although_IN rare_JJ ,_, is_VBZ a_DT well_RB known_VBN
        complication_NN of_IN arterial_NN cannulation_NN [_NN 3_CD ,_, 4_CD ,_, 5_CD ]_NN and_CC this_DT
        problem_NN may_MD be_VB exacerbated_VBN in_IN patients_NNS with_IN sepsis_NN who_WP have_VBP
        microcirculatory_NN disturbances_NNS including_VBG slowing_NN of_IN
        capillary_JJ blood_NN flow_NN and_CC local_JJ arteriolar_NN constriction_NN [_NN
        6_CD ]_NN ,_, and_CC who_WP also_RB often_RB require_VB vasopressors_NNS for_IN
        hypotension_NN ._. A_DT clinical_JJ concern_NN exists_VBZ ,_, therefore_RB ,_, about_IN
        the_DT safety_NN of_IN femoral_NN artery_NN cannulation_NN in_IN the_DT critically_RB
        ill_JJ patients_NNS who_WP may_MD potentially_RB benefit_VB from_IN this_DT
        sophisticated_JJ monitoring_NN ._.
        Following_VBG insertion_NN of_IN the_DT femoral_NN artery_NN catheter_NN ,_,
        peripheral_JJ tissue_NN perfusion_NN is_VBZ usually_RB assessed_VBN by_IN regular_JJ
        clinical_JJ examination_NN of_IN skin_NN colour_NN ,_, capillary_JJ return_NN and_CC
        temperature_NN ,_, all_DT of_IN which_WDT are_VBP subjective_JJ measures_NNS ._. The_DT
        presence_NN or_CC absence_NN of_IN pedal_VB pulses_NNS and_CC measurement_NN of_IN
        maximum_NN calf_NN occlusion_NN pressures_NNS assess_VBP only_RB gross_JJ changes_NNS
        in_IN large_JJ vessel_NN flow_NN ._. Single_NNP point_NN laser_NN Doppler_NNP flowmetry_NN
        has_VBZ been_VBN employed_VBN successfully_RB as_IN a_DT technique_NN for_IN measuring_VBG
        skin_NN blood_NN flow_NN [_NN 7_CD ,_, 8_CD ,_, 9_CD ,_, 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ,_, 16_CD ,_, 17_CD ,_,
        18_CD ,_, 19_CD ,_, 20_CD ,_, 21_CD ]_NN ,_, but_CC there_EX are_VBP several_JJ methodological_JJ
        drawbacks_NNS associated_VBN with_IN the_DT technique_NN ._. These_DT include_VBP the_DT
        potential_JJ influence_NN of_IN local_JJ perfusion_NN by_IN contact_NN with_IN
        traditional_JJ laser_NN Doppler_NNP probes_NNS [_NN 18_CD ]_NN ,_, the_DT small_JJ sampling_VBG
        area_NN of_IN single_JJ point_NN measurements_NNS which_WDT ,_, because_IN of_IN the_DT
        spatial_NN heterogeneity_NN of_IN the_DT cutaneous_JJ microvasculature_NN ,_,
        might_MD not_RB be_VB representative_NN of_IN overall_JJ flow_NN [_NN 22_CD ,_, 23_CD ]_NN ,_, and_CC
        the_DT long_JJ time_NN needed_VBN to_TO make_VB multiple_JJ measurements_NNS ._.
        Scanning_NNP laser_NN Doppler_NNP flowmetry_NN is_VBZ a_DT recent_JJ development_NN
        [_NN 24_CD ,_, 25_CD ]_NN of_IN the_DT laser_NN Doppler_NNP technique_NN that_WDT may_MD overcome_VB
        these_DT drawbacks_NNS ._. A_DT laser_NN beam_NN is_VBZ directed_VBN to_TO scan_VB over_IN a_DT
        predetermined_VBN area_NN and_CC thousands_NNS of_IN individual_JJ measurements_NNS
        of_IN perfusion_NN are_VBP made_VBN ._. These_DT data_NNS are_VBP stored_VBN electronically_RB
        and_CC converted_VBN into_IN both_DT greyscale_NN photographic_JJ and_CC
        colour-coded_JJ perfusion_NN images_NNS ._. Subsequently_RB ,_, regions_NNS of_IN
        interest_NN can_MD be_VB outlined_VBN on_IN these_DT images_NNS and_CC mean_VB perfusion_NN
        within_IN them_PRP calculated_VBD ._.
        This_DT new_JJ technique_NN was_VBD used_VBN to_TO assess_VB the_DT influence_NN upon_IN
        pedal_VB cutaneous_JJ perfusion_NN of_IN the_DT insertion_NN of_IN a_DT femoral_NN
        artery_NN catheter_NN for_IN the_DT purpose_NN of_IN measuring_VBG ITBV_NNP ,_, EVLW_NNP and_CC
        cardiac_JJ output_NN (_( CO_NNP )_) using_VBG the_DT Pulsion_NNP COLD_NNP system_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        Following_VBG hospital_NN ethical_JJ committee_NN approval_NN ,_, and_CC after_IN
        obtaining_VBG informed_VBN consent_NN ,_, 10_CD patients_NNS in_IN a_DT single_JJ
        intensive_JJ care_NN unit_NN were_VBD studied_VBN ._. All_DT were_VBD intubated_JJ ,_,
        ventilated_VBD and_CC sedated_JJ and_CC required_VBN cardiovascular_JJ support_NN
        with_IN vasoactive_JJ drugs_NNS ._. Following_VBG the_DT clinical_JJ decision_NN to_TO
        insert_VB a_DT femoral_NN artery_NN catheter_NN the_DT patients_NNS were_VBD
        randomized_JJ to_TO right_NN or_CC left_VBD leg_NN catheterization_NN ._. None_NN had_VBD
        either_CC historical_JJ nor_CC current_JJ clinical_JJ evidence_NN of_IN
        peripheral_JJ arterial_NN disease_NN ._. Room_NNP temperature_NN was_VBD kept_VBN
        constant_JJ at_IN 22_CD °_NN C_NNP and_CC both_DT legs_NNS were_VBD uncovered_VBN for_IN a_DT 15_CD min_NN
        equilibrium_NN period_NN ._. All_DT measurements_NNS were_VBD made_VBN immediately_RB
        before_IN and_CC after_IN insertion_NN of_IN the_DT femoral_NN artery_NN catheter_NN
        (_( Pulsiocath_NNP 2024_CD L_NNP ,_, Pulsion_NNP ,_, Munich_NNP ,_, Germany_NNP )_) and_CC 24_CD h_NN
        subsequently_RB ._. All_DT catheterizations_NNS were_VBD performed_VBN by_IN a_DT
        single_JJ individual_JJ and_CC involved_VBD a_DT standard_JJ Seldinger_NNP
        technique_NN and_CC insertion_NN of_IN a_DT 4_CD ._. 0_CD F_NN catheter_NN through_IN a_DT 4_CD ._. 5_CD F_NN
        sheath_NN ._.
        The_DT mean_JJ systemic_JJ arterial_NN blood_NN pressure_NN was_VBD measured_VBN
        using_VBG a_DT 20_CD -_: gauge_VB cannula_NN positioned_VBN within_IN the_DT radial_NN
        artery_NN ._. Calf_NNP occlusion_NN pressure_NN was_VBD measured_VBN using_VBG a_DT hand_NN
        held_VBD sonic_JJ Doppler_NNP and_CC a_DT standard_JJ sphygmomanometer_NN cuff_VB ,_,
        the_DT maximum_NN in_IN either_DT the_DT dorsalis_NNS pedis_NNS or_CC posterior_NN
        tibial_NN artery_NN being_VBG recorded_VBN as_IN the_DT value_NN ._. Vasoactive_NNP drug_NN
        doses_NNS were_VBD recorded_VBN at_IN the_DT time_NN of_IN each_DT measurement_NN ._.
        Laser_NNP Doppler_NNP scans_VBZ (_( Moor_NNP LDI_NNP ,_, Moor_NNP Instruments_NNP Ltd_NNP ,_,
        Axminster_NNP ,_, Devon_NNP ,_, UK_NNP ;_: approximate_JJ cost_NN £_NN 30_CD 000_CD )_) of_IN the_DT
        plantar_NN aspect_NN of_IN both_DT feet_NNS were_VBD made_VBN from_IN a_DT distance_NN of_IN 38_CD
        cm_NN ._. This_DT distance_NN was_VBD chosen_VBN as_IN the_DT closest_JJS from_IN which_WDT a_DT
        scan_VB of_IN the_DT entire_JJ sole_NN of_IN the_DT foot_NN could_MD always_RB be_VB
        included_VBN ._. In_IN each_DT case_NN ,_, the_DT laser_NN Doppler_NNP scanner_NN was_VBD
        positioned_VBN to_TO ensure_VB that_IN the_DT laser_NN beam_NN was_VBD perpendicular_NN
        to_TO the_DT patient_NN 's_POS feet_NNS ._. From_IN each_DT set_NN of_IN data_NNS ,_, two_CD images_NNS
        were_VBD simultaneously_RB produced_VBN and_CC stored_VBN electronically_RB :_: a_DT
        greyscale_NN photographic_JJ image_NN and_CC a_DT colour-coded_JJ perfusion_NN
        map_NN ._. On_IN the_DT photographic_JJ image_NN ,_, the_DT sole_NN of_IN the_DT foot_NN was_VBD
        outlined_VBN ,_, which_WDT equated_VBN to_TO a_DT mean_NN of_IN over_IN 17_CD 000_CD individual_JJ
        perfusion_NN measurements_NNS on_IN the_DT corresponding_JJ blood_NN flow_NN
        image_NN ,_, allowing_VBG calculation_NN of_IN mean_NN perfusion_NN units_NNS (_( PUs_NNP )_)
        for_IN each_DT foot_NN for_IN comparison_NN with_IN the_DT other_JJ side_NN ._. The_DT
        results_NNS were_VBD analysed_JJ statistically_RB using_VBG the_DT Mann-_NNP Whitney_NNP
        U-_NNP test_NN ._.
      
      
        Results_NNS
        The_DT laser_NN Doppler_NNP scans_NNS were_VBD easy_JJ to_TO make_VB (_( Fig_NNP ._. 1_LS )_) and_CC
        the_DT computer_NN software_NN supplied_VBN with_IN the_DT scanner_NN allowed_VBD
        simple_JJ measurement_NN of_IN mean_NN perfusion_NN within_IN the_DT outlined_VBN
        foot_NN ._. There_EX were_VBD no_DT complications_NNS associated_VBN with_IN catheter_NN
        insertion_NN ._.
        There_EX were_VBD no_DT significant_JJ changes_NNS in_IN mean_NN systemic_JJ
        arterial_NN blood_NN pressure_NN or_CC maximal_NN occlusion_NN pressures_NNS
        between_IN preinsertion_NN and_CC postinsertion_NN measurements_NNS (_( Table_NNP
        1_LS )_) ._. Furthermore_RB ,_, there_EX were_VBD no_DT significant_JJ changes_NNS in_IN any_DT
        of_IN these_DT parameters_NNS when_WRB they_PRP were_VBD measured_VBN 24_CD h_NN following_VBG
        catheterization_NN ._.
        All_DT the_DT patients_NNS were_VBD receiving_VBG vasopressor_NN agents_NNS over_IN
        the_DT 24_CD h_NN study_NN period_NN (_( norepinephrine_NN ,_, 0_CD ._. 08_CD -_: 0_CD ._. 78_CD μg_NN /_NN kg_NN per_IN
        min_NN ;_: and_CC epinephrine_NN ,_, 0_CD ._. 47_CD -_: 0_CD ._. 92_CD μg_NN /_NN kg_NN per_IN min_NN )_) ._. Dobutamine_NNP
        (_( 0_CD ._. 03_CD -_: 16_CD ._. 6_CD μg_NN /_NN kg_NN per_IN min_NN )_) was_VBD also_RB administered_VBN to_TO seven_CD
        patients_NNS ._. No_DT alterations_NNS to_TO the_DT patients_NNS '_POS doses_NNS were_VBD made_VBN
        between_IN arterial_NN catheterization_NN and_CC the_DT first_JJ
        post-catheterisation_JJ measurement_NN ._. There_EX was_VBD no_DT significant_JJ
        change_NN in_IN any_DT of_IN these_DT drug_NN dosages_NNS 24_CD h_NN following_VBG catheter_NN
        insertion_NN (_( 
        P_NN values_NNS for_IN norepinephrine_NN ,_,
        epinephrine_NN and_CC dobutamine_NN 0_CD ._. 65_CD ,_, 0_CD ._. 89_CD and_CC 0_CD ._. 11_CD ,_,
        respectively_RB )_) ._.
        There_EX was_VBD no_DT significant_JJ reduction_NN in_IN foot_NN cutaneous_JJ
        perfusion_NN measured_VBN with_IN the_DT laser_NN Doppler_NNP scanner_NN either_CC
        between_IN the_DT first_JJ two_CD or_CC between_IN the_DT second_JJ and_CC final_JJ
        measurements_NNS following_VBG insertion_NN of_IN the_DT catheters_NNS (_( Table_NNP
        2_LS )_) ._. Prior_RB to_TO catheter_NN insertion_NN ,_, the_DT mean_JJ difference_NN in_IN
        foot_NN perfusion_NN (_( insertion_NN minus_CC noninsertion_NN legs_NNS )_) was_VBD 12_CD ._. 5_LS
        PUs_NNP ;_: following_VBG insertion_NN this_DT value_NN was_VBD 16_CD ._. 8_CD PUs_NNP (_( 
        P_NN =_SYM 0_CD ._. 22_CD )_) and_CC ,_, at_IN 24_CD h_NN ,_, -_: 2_CD ._. 9_CD PUs_NNP (_( 
        P_NN =_SYM 0_CD ._. 8_CD )_) ._.
      
      
        Discussion_NNP
        ARDS_NNP describes_VBZ a_DT pathological_JJ syndrome_NN characterized_VBN by_IN
        an_DT immunological_JJ reaction_NN to_TO various_JJ insults_NNS that_IN results_NNS
        in_IN diffuse_NN alveolar_NN damage_NN ._. It_PRP is_VBZ commonly_RB associated_VBN with_IN
        sepsis_NN and_CC has_VBZ a_DT mortality_NN of_IN 50_CD -_: 70_CD %_NN ._. Mitchell_NNP 
        et_CC al_NN [_NN 1_CD ]_NN showed_VBD that_IN patients_NNS with_IN
        ARDS_NNP managed_VBD with_IN diuresis_NNS /_NN fluid_JJ restriction_NN and_CC guided_VBN by_IN
        the_DT measurement_NN of_IN EVLW_NNP had_VBD significantly_RB less_JJR EVLW_NNP than_IN
        those_DT managed_VBN conventionally_RB using_VBG the_DT PAOP_NNP ;_: furthermore_RB ,_, a_DT
        >_NN 15_CD %_NN reduction_NN in_IN EVLW_NNP was_VBD associated_VBN with_IN a_DT reduction_NN
        in_IN ventilator_NN and_CC ICU_NNP days_NNS ._. However_RB ,_, fluid_JJ management_NN in_IN
        patients_NNS with_IN ARDS_NNP and_CC septic_JJ shock_NN can_MD be_VB difficult_JJ ._. Fluid_NNP
        restriction_NN in_IN patients_NNS with_IN septic_JJ shock_NN may_MD exacerbate_VB
        haemodynamic_JJ instability_NN ,_, increase_NN inotropic_JJ requirement_NN
        and_CC lead_VB to_TO vital_JJ organ_NN hypoperfusion_NN ._. Thus_RB ,_, if_IN this_DT
        strategy_NN is_VBZ to_TO be_VB used_VBN ,_, circulatory_NN volume_NN status_NN and_CC
        end-organ_JJ function_NN must_MD be_VB carefully_RB monitored_VBN ._.
        Following_VBG insertion_NN of_IN a_DT femoral_NN artery_NN catheter_NN prior_RB
        to_TO the_DT measurement_NN of_IN EVLW_NNP and_CC ITBV_NNP using_VBG double-indicator_JJ
        dilution_NN ,_, peripheral_JJ perfusion_NN has_VBZ usually_RB been_VBN assessed_VBN by_IN
        regular_JJ clinical_JJ examination_NN for_IN capillary_JJ return_NN ,_, warmth_NN ,_,
        presence_NN of_IN pedal_VB pulses_NNS and_CC measurement_NN of_IN maximum_NN calf_NN
        occlusion_NN pressures_NNS ._. More_JJR objective_NN techniques_NNS of_IN measuring_VBG
        cutaneous_JJ perfusion_NN are_VBP available_JJ [_NN 26_CD ]_NN ,_, but_CC these_DT do_VBP not_RB
        lend_VB themselves_PRP to_TO everyday_JJ clinical_JJ use_NN ._. Conventional_JJ
        single-point_JJ laser_NN Doppler_NNP flowmetry_NN (_( LDF_NNP )_) has_VBZ been_VBN
        successfully_RB used_VBN to_TO assess_VB the_DT cutaneous_JJ microcirculation_NN
        in_IN a_DT variety_NN of_IN clinical_JJ applications_NNS ._. Several_JJ studies_NNS have_VBP
        demonstrated_VBN the_DT ability_NN of_IN LDF_NNP to_TO distinguish_VB patients_NNS
        with_IN established_VBN peripheral_JJ vascular_NN disease_NN from_IN normal_JJ
        patients_NNS [_NN 7_CD ,_, 8_CD ]_NN ,_, and_CC it_PRP has_VBZ been_VBN used_VBN to_TO assess_VB the_DT
        viability_NN of_IN tissue_NN flaps_NNS [_NN 10_CD ,_, 11_CD ,_, 12_CD ]_NN ;_: LDF_NNP has_VBZ also_RB been_VBN
        useful_JJ in_IN the_DT measurement_NN of_IN cutaneous_JJ perfusion_NN following_VBG
        percutaneous_JJ transluminal_NN angioplasty_NN [_NN 13_CD ]_NN in_IN patients_NNS
        with_IN peripheral_JJ vascular_NN disease_NN and_CC following_VBG the_DT
        administration_NN of_IN vasoactive_JJ agents_NNS [_NN 14_CD ]_NN ._.
        Several_JJ comparative_JJ studies_NNS have_VBP validated_JJ LDF_NNP with_IN
        other_JJ methods_NNS of_IN measuring_VBG skin_NN blood_NN flow_NN [_NN 15_CD ,_, 16_CD ]_NN ,_, but_CC
        the_DT failure_NN of_IN the_DT technique_NN to_TO gain_VB widespread_JJ acceptance_NN
        in_IN clinical_JJ practice_NN is_VBZ secondary_JJ to_TO the_DT methodological_JJ
        drawbacks_NNS associated_VBN with_IN it_PRP ._. Variation_NNP in_IN the_DT number_NN of_IN
        perfused_JJ capillaries_NNS and_CC local_JJ differences_NNS in_IN the_DT
        vasodilator_NN response_NN characteristics_NNS of_IN vessels_NNS cause_VBP local_JJ
        differences_NNS in_IN blood_NN flow_NN of_IN up_IN to_TO sixfold_RB [_NN 17_CD ]_NN ._. The_DT
        sampling_VBG area_NN of_IN single-point_JJ laser_NN Doppler_NNP probes_NNS is_VBZ
        dependent_JJ upon_IN their_PRP$ geometry_NN ,_, but_CC is_VBZ usually_RB between_IN 1_CD and_CC
        3_CD mm_NN 3_CD and_CC ,_, because_IN of_IN the_DT spatial_NN heterogeneity_NN of_IN tissue_NN
        blood_NN flow_NN ,_, single_JJ measurements_NNS may_MD not_RB be_VB representative_NN
        of_IN overall_JJ local_JJ cutaneous_JJ blood_NN flow_NN [_NN 22_CD ,_, 23_CD ]_NN ._. It_PRP has_VBZ
        been_VBN suggested_VBN that_DT calculation_NN of_IN the_DT mean_NN of_IN up_IN to_TO six_CD
        measurements_NNS each_DT taken_VBN over_IN 30_CD s_VBZ will_MD reduce_VB the_DT error_NN ,_,
        but_CC clearly_RB this_DT is_VBZ time_NN consuming_NN [_NN 22_CD ]_NN ._. Direct_JJ contact_NN
        with_IN the_DT skin_NN is_VBZ necessary_JJ with_IN traditional_JJ laser_NN Doppler_NNP
        probes_NNS ,_, and_CC there_EX are_VBP frequent_JJ difficulties_NNS in_IN maintaining_VBG
        the_DT same_JJ point_NN of_IN contact_NN ,_, making_VBG sequential_NN measurements_NNS
        open_JJ to_TO inaccuracy_NN [_NN 27_CD ]_NN furthermore_RB ,_, pressure_NN may_MD
        influence_VB local_JJ perfusion_NN itself_PRP [_NN 18_CD ]_NN ._.
        The_DT recent_JJ development_NN of_IN the_DT scanning_VBG laser_NN Doppler_NNP
        technique_NN [_NN 24_CD ,_, 25_CD ]_NN allows_VBZ the_DT rapid_JJ measurement_NN of_IN flow_NN
        over_IN a_DT large_RB predetermined_VBN area_NN and_CC ,_, by_IN collecting_VBG
        reflected_VBN light_JJ via_IN mirrors_VBZ ,_, the_DT previously_RB requisite_JJ probe_NN
        and_CC optic_JJ cables_NNS are_VBP dispensed_VBD with_IN and_CC there_EX is_VBZ no_DT contact_NN
        with_IN the_DT skin_NN itself_PRP ._. The_DT scanner_NN is_VBZ mounted_VBN on_IN a_DT portable_JJ
        stand_NN and_CC can_MD be_VB positioned_VBN to_TO allow_VB imaging_NN around_IN a_DT 360_CD °_NN
        axis_NNS (_( Figs_NNP 2_CD and_CC 3_LS )_) ._. It_PRP is_VBZ run_VBN by_IN a_DT portable_JJ notebook_NN
        computer_NN which_WDT allows_VBZ the_DT operator_NN to_TO predetermine_NN the_DT area_NN
        in_IN which_WDT flow_VBP is_VBZ to_TO be_VB sampled_VBN ._. The_DT laser_NN is_VBZ then_RB scanned_JJ
        in_IN a_DT continuous_JJ rasta_NN pattern_NN over_IN the_DT tissue_NN ._. A_DT
        measurement_NN is_VBZ made_VBN every_DT 4_CD ms_NNS ,_, and_CC up_IN to_TO 65_CD 500_CD individual_JJ
        measurements_NNS can_MD be_VB made_VBN in_IN less_JJR than_IN 5_CD min_NN ._. The_DT perfusion_NN
        data_NN is_VBZ transformed_VBN instantaneously_RB into_IN a_DT greyscale_NN
        photographic_JJ image_NN and_CC a_DT corresponding_JJ colour_NN perfusion_NN
        image_NN is_VBZ generated_VBN ,_, with_IN different_JJ colours_NNS representing_VBG
        different_JJ levels_NNS of_IN flow_NN ._. The_DT associated_VBN computer_NN software_NN
        allows_VBZ either_CC the_DT whole_JJ image_NN or_CC smaller_JJR regions_NNS of_IN
        interest_NN on_IN either_DT the_DT colour_NN or_CC photographic_JJ images_NNS to_TO be_VB
        outlined_VBN and_CC mean_VB perfusion_NN calculated_VBN within_IN this_DT
        area_NN ._.
        The_DT technique_NN is_VBZ noninvasive_JJ and_CC ,_, because_IN of_IN the_DT
        multiple_JJ measurements_NNS made_VBN over_IN a_DT wide_JJ area_NN ,_, the_DT error_NN
        associated_VBN with_IN the_DT spatial_NN heterogeneity_NN of_IN cutaneous_JJ
        vessels_NNS when_WRB making_VBG sequential_NN measurements_NNS from_IN the_DT same_JJ
        point_NN is_VBZ removed_VBN ._. The_DT technique_NN has_VBZ been_VBN validated_JJ against_IN
        flow_NN models_NNS ,_, conventional_JJ single-point_JJ laser_NN Doppler_NNP
        flowmetry_NN and_CC other_JJ established_VBN methods_NNS of_IN assessing_VBG skin_NN
        perfusion_NN [_NN 28_CD ,_, 29_CD ,_, 30_CD ,_, 31_CD ]_NN ,_, and_CC has_VBZ been_VBN used_VBN to_TO measure_VB
        perfusion_NN in_IN hepatic_JJ [_NN 32_CD ]_NN and_CC colonic_JJ [_NN 33_CD ]_NN tissue_NN ._.
        Amongst_NNP cutaneous_JJ applications_NNS it_PRP has_VBZ been_VBN successfully_RB
        used_VBN to_TO assess_VB burn_VB depth_NN [_NN 34_CD ]_NN ,_, skin_NN flap_NN viability_NN [_NN 18_CD ]_NN ,_,
        the_DT cutaneous_JJ response_NN to_TO inflammation_NN [_NN 35_CD ]_NN and_CC the_DT
        therapeutic_JJ response_NN of_IN psoriatic_JJ plaques_NNS to_TO psoralen_NN and_CC
        long-wave_JJ ultraviolet-_NN A_DT radiation_NN therapy_NN (_( PUVA_NNP )_) treatment_NN
        [_NN 35_CD ]_NN ._. Other_JJ clinical_JJ applications_NNS of_IN laser_NN Doppler_NNP imaging_NN
        to_TO the_DT measurement_NN of_IN cutaneous_JJ blood_NN flow_NN include_VBP the_DT
        effects_NNS of_IN postural_NN changes_NNS in_IN blood_NN flow_NN in_IN venous_JJ leg_NN
        ulcers_NNS [_NN 20_CD ]_NN ,_, the_DT assessment_NN of_IN digital_JJ perfusion_NN following_VBG
        arterial_NN repair_NN [_NN 21_CD ]_NN ,_, skin_NN perfusion_NN overlying_VBG benign_JJ and_CC
        malignant_JJ breast_NN disease_NN [_NN 36_CD ]_NN and_CC the_DT effect_NN of_IN
        prostaglandins_NNS on_IN ischaemic_JJ ulcers_NNS [_NN 37_CD ]_NN ._.
        Femoral_NNP artery_NN catheterization_NN has_VBZ an_DT associated_VBN limb_NN
        threatening_VBG complication_NN rate_NN of_IN up_IN to_TO 1_CD %_NN and_CC can_MD
        jeopardise_NN peripheral_JJ perfusion_NN [_NN 5_CD ]_NN ._. Femoral_NNP arterial_NN
        trauma_NN with_IN associated_VBN thrombosis_NNS and_CC limb_NN threatening_VBG
        ischaemia_NN following_VBG catheterization_NN will_MD be_VB clinically_RB
        obvious_JJ ._. Standard_JJ postcatheterization_NN observations_NNS usually_RB
        involve_VBP measurement_NN of_IN calf_NN occlusion_NN pressures_NNS and_CC ,_, in_IN
        this_DT study_NN ,_, these_DT were_VBD not_RB influenced_VBN by_IN insertion_NN of_IN the_DT
        catheter_NN ._.
        More_RBR subtle_JJ changes_NNS in_IN cutaneous_JJ flow_NN may_MD be_VB more_RBR
        difficult_JJ to_TO establish_VB using_VBG clinical_JJ observation_NN ,_,
        particularly_RB in_IN patients_NNS who_WP are_VBP receiving_VBG vasoactive_JJ drugs_NNS
        secondary_JJ to_TO their_PRP$ septic_JJ condition_NN ;_: this_DT group_NN of_IN patients_NNS
        may_MD be_VB particularly_RB at_IN risk_NN of_IN critical_JJ peripheral_JJ
        ischaemia_NN ._. Furthermore_RB ,_, by_IN their_PRP$ very_RB nature_NN ,_, these_DT
        techniques_NNS are_VBP wholly_RB subjective_JJ ._. Scanning_NNP laser_NN Doppler_NNP
        flowmetry_NN allows_VBZ objective_NN measurement_NN of_IN cutaneous_JJ blood_NN
        flow_NN and_CC is_VBZ able_JJ to_TO detect_VB changes_NNS in_IN cutaneous_JJ perfusion_NN
        that_WDT are_VBP not_RB detected_VBN by_IN the_DT human_JJ eye_NN ._. We_PRP were_VBD not_RB able_JJ to_TO
        demonstrate_VB any_DT significant_JJ alteration_NN in_IN pedal_VB cutaneous_JJ
        perfusion_NN either_CC immediately_RB following_VBG catheterization_NN or_CC
        24_CD h_NN later_RB ._. Despite_IN the_DT vasoactive_JJ drugs_NNS that_IN the_DT patients_NNS
        were_VBD receiving_VBG ,_, the_DT presence_NN of_IN the_DT femoral_NN catheter_NN did_VBD
        not_RB appear_VB to_TO reduce_VB the_DT blood_NN supply_NN to_TO the_DT skin_NN ._.
        Femoral_NNP artery_NN catheterization_NN for_IN the_DT purpose_NN of_IN
        measuring_VBG ITBW_NNP ,_, EVLW_NNP and_CC CO_NNP does_VBZ not_RB compromise_VB peripheral_JJ
        cutaneous_JJ perfusion_NN in_IN critically_RB ill_JJ patients_NNS ._. Scanning_NNP
        laser_NN Doppler_NNP flowmetry_NN is_VBZ easily_RB used_VBN to_TO assess_VB cutaneous_JJ
        perfusion_NN in_IN the_DT ICU_NNP and_CC provides_VBZ an_DT objective_NN alternative_NN
        to_TO standard_JJ clinical_JJ evaluation_NN of_IN limb_NN blood_NN flow_NN ._. It_PRP also_RB
        has_VBZ the_DT potential_NN to_TO assess_VB cutaneous_JJ perfusion_NN following_VBG
        other_JJ interventions_NNS ,_, either_CC mechanical_JJ or_CC
        pharmacological_JJ ._.
      
    
  
